What is CLSA's rating on CRL?

CLSA rates CRL Hold, a neutral rating, as of Jul 20, 2026.

When did CLSA last change its view on CRL?

On Jul 20, 2026, CLSA downgrades to Hold from Outperform, price target $219.

CLSA CRL price target and rating history

Charles River Laboratories International Inc. (CRL) · Health Care

CLSA rates Charles River Laboratories International Inc. (CRL) Hold with a $219 price target, as of its latest action on Jul 20, 2026. It has published 5 rating actions on CRL since October 2024, including 2 upgrades and 2 downgrades. Across 5 firms with a CRL price target in the last 12 months, the median target is $220. CLSA's target matches it.

Current rating: Hold
Price target: $219
Median target, all firms: $220
Actions on CRL: 5

CLSA price target on CRL

CLSA price target on CRL, each point a stated target, October 2024 to July 2026.

Every CLSA rating on CRL

Jul 20, 2026
DowngradeCLSA downgrades to Hold from Outperform, price target $219
May 29, 2026
UpgradeCLSA upgrades to Outperform from Hold, price target $219
Nov 18, 2024
DowngradeCLSA downgrades to Underperform from Hold, price target $164
Nov 7, 2024
UpgradeCLSA upgrades to Hold from Underperform, price target $205
Oct 23, 2024
InitiateCLSA starts coverage at Underperform, price target $167

How other firms rate CRL

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
UBS	Buy	$357	Sep 30, 2026
CLSA	Hold	$219	Jul 20, 2026
Morgan Stanley	Overweight	$220	Jun 17, 2026
RBC Capital Markets	Outperform	$215	Apr 14, 2026
BofA Securities	Buy	$225	Dec 15, 2025
Argus Research	Buy		Nov 17, 2025

Questions about CLSA and CRL

What is CLSA's price target for CRL?: CLSA's latest stated price target for Charles River Laboratories International Inc. (CRL) is $219, from its action on Jul 20, 2026.
What is CLSA's rating on CRL?: CLSA rates CRL Hold, a neutral rating, as of Jul 20, 2026.
When did CLSA last change its view on CRL?: On Jul 20, 2026, CLSA downgrades to Hold from Outperform, price target $219.
How does CLSA's CRL target compare with other analysts?: Across 5 firms with a CRL price target in the last 12 months, the median target is $220. CLSA's target matches it.

More CRL rating histories

All CLSA ratings CRL news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.